BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,359,216 | -27.2% | 66,890 | -8.4% | 0.01% | -28.6% |
Q2 2023 | $4,614,358 | +37.1% | 73,012 | -2.4% | 0.01% | +40.0% |
Q1 2023 | $3,364,937 | +1.3% | 74,793 | -1.4% | 0.01% | 0.0% |
Q4 2022 | $3,321,587 | -32.7% | 75,818 | +1.3% | 0.01% | -37.5% |
Q3 2022 | $4,932,000 | +28.4% | 74,855 | -1.5% | 0.01% | +33.3% |
Q2 2022 | $3,840,000 | -17.5% | 76,029 | +4.4% | 0.01% | 0.0% |
Q1 2022 | $4,653,000 | -45.0% | 72,833 | -7.8% | 0.01% | -40.0% |
Q4 2021 | $8,459,000 | +6.8% | 78,978 | +2.5% | 0.01% | 0.0% |
Q3 2021 | $7,919,000 | +4.8% | 77,025 | -10.3% | 0.01% | +11.1% |
Q2 2021 | $7,555,000 | -12.4% | 85,888 | -3.2% | 0.01% | -18.2% |
Q1 2021 | $8,624,000 | -13.6% | 88,692 | -0.3% | 0.01% | -21.4% |
Q4 2020 | $9,978,000 | +21.1% | 88,974 | +0.1% | 0.01% | +7.7% |
Q3 2020 | $8,240,000 | +29.3% | 88,888 | +8.7% | 0.01% | +18.2% |
Q2 2020 | $6,375,000 | +34.0% | 81,737 | +0.4% | 0.01% | +10.0% |
Q1 2020 | $4,759,000 | -20.4% | 81,377 | +9.1% | 0.01% | 0.0% |
Q4 2019 | $5,975,000 | +6.9% | 74,589 | -2.0% | 0.01% | -9.1% |
Q3 2019 | $5,591,000 | -21.2% | 76,096 | +1.2% | 0.01% | -21.4% |
Q2 2019 | $7,092,000 | +39.9% | 75,187 | +18.8% | 0.01% | +40.0% |
Q1 2019 | $5,068,000 | +45.3% | 63,310 | -2.2% | 0.01% | +25.0% |
Q4 2018 | $3,489,000 | -29.3% | 64,718 | +2.3% | 0.01% | -20.0% |
Q3 2018 | $4,938,000 | +22.9% | 63,259 | -0.0% | 0.01% | +25.0% |
Q2 2018 | $4,017,000 | -32.4% | 63,281 | -2.3% | 0.01% | -38.5% |
Q1 2018 | $5,940,000 | +17.5% | 64,776 | -3.4% | 0.01% | +30.0% |
Q4 2017 | $5,056,000 | +16.7% | 67,047 | +7.8% | 0.01% | 0.0% |
Q3 2017 | $4,332,000 | +24.2% | 62,186 | -9.7% | 0.01% | +42.9% |
Q2 2017 | $3,489,000 | +82.3% | 68,861 | +43.9% | 0.01% | +75.0% |
Q1 2017 | $1,914,000 | +65.4% | 47,862 | +16.0% | 0.00% | +100.0% |
Q4 2016 | $1,157,000 | -7.8% | 41,262 | -2.4% | 0.00% | -33.3% |
Q3 2016 | $1,255,000 | +47.6% | 42,262 | +0.7% | 0.00% | +50.0% |
Q2 2016 | $850,000 | +137.4% | 41,962 | +111.4% | 0.00% | +100.0% |
Q1 2016 | $358,000 | -21.8% | 19,853 | +14.3% | 0.00% | 0.0% |
Q4 2015 | $458,000 | +26.2% | 17,371 | +2.1% | 0.00% | 0.0% |
Q3 2015 | $363,000 | -19.9% | 17,009 | -0.6% | 0.00% | 0.0% |
Q2 2015 | $453,000 | – | 17,109 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |